LCID
Lucid Group, Inc.
LCID has lower modeled downside risk, despite its lower overall score.
NDLS
Noodles & Company
NDLS has a slight edge over LCID overall, supported by stronger modeled upside.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
NDLS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Weak |
NDLS's revenue, profitability and cash flow are currently stable, but its balance sheet is weak.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
NDLS PE Valuation
NDLS has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
NDLS Forward outlook
There aren't enough analyst estimates for NDLS to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over NDLS on earnings, with more consistent year-over-year improvement.
NDLS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$3.97 | +$3.55 |
| Q1 2026 | -$6.34 | +$0.54 |
| Q4 2025 | -$7.36 | -$0.96 |
| Q3 2025 | -$7.92 | -$2.16 |
| Q2 2025 | -$7.52 | -$3.12 |
| Q1 2025 | -$6.88 | -$4.64 |
| Q4 2024 | -$6.40 | -$4.72 |
| Q3 2024 | -$5.76 | -$5.28 |
NDLS lost $3.97 per share over the past year, a smaller loss than the year before.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over NDLS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
NDLS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $127M | +0.5% |
| Q1 2026 | $123.8M | 0% |
| Q4 2025 | $122.8M | +0.8% |
| Q3 2025 | $122.1M | -0.5% |
| Q2 2025 | $126.4M | -0.7% |
| Q1 2025 | $123.8M | +2% |
| Q4 2024 | $121.8M | -2% |
| Q3 2024 | $122.8M | -4% |
NDLS's revenue grew through 2021 and has held roughly level since: $127M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1.2% | +11 points |
| Q1 2026 | -0.7% | +4.5 points |
| Q4 2025 | -3.3% | +2.7 points |
| Q3 2025 | -5.2% | -1.3 points |
| Q2 2025 | -12% | -2.7 points |
| Q1 2025 | -5.2% | -1.8 points |
| Q4 2024 | -6% | -2.4 points |
| Q3 2024 | -3.9% | -5.5 points |
NDLS has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
NDLS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $1.8M | +$6M |
| Q1 2026 | $3.9M | +253% |
| Q4 2025 | -$3.4M | +$10.4M |
| Q3 2025 | $1.4M | +$2.8M |
| Q2 2025 | -$4.3M | +$205K |
| Q1 2025 | $1.1M | +$2.8M |
| Q4 2024 | -$13.8M | +$1.4M |
| Q3 2024 | -$1.3M | -132% |
NDLS has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NDLS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 8.7x | High |
| Q4 2024 | 77.3x | High |
| Q3 2024 | 18.9x | High |
| Q2 2024 | 7.8x | High |
| Q1 2024 | 3.8x | Elevated |
| Q4 2023 | 3.6x | Elevated |
| Q3 2023 | 2.3x | Moderate |
| Q2 2023 | 2.4x | Moderate |
NDLS's net debt is about 8.7 years of its operating earnings (EBITDA), up from 3.8 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
NDLS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.6 | Neutral |
| Stochastic | 38.4 | Neutral |
NDLS's weekly RSI is 52 (neutral) and its Stochastic is 38 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
NDLS PE vs Consumer Cyclical Sector
| Metric | NDLS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
NDLS has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
NDLS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.6 | 1% above |
| 20 week MA | $14.4 | 4.6% below |
| 50 week MA | $10.9 | 26% above |
| 100 week MA | $9.01 | 53% above |
| 200 week MA | $15.4 | 11% below |
NDLS has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
NDLS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $44.4 | $63.3 | +43% |
| 2021 | $63.3 | $75.8 | +20% |
| 2022 | $75.8 | $41.3 | -46% |
| 2023 | $41.3 | $25.2 | -39% |
| 2024 | $25.2 | $4.89 | -81% |
| 2025 | $4.89 | $5.66 | +16% |
| 2026 YTD | $5.66 | $13.8 | +143% |
NDLS has the edge over LCID on returns for 2026, with the stronger performance.